INTRODUCTION
Protein tyrosine phosphatases (PTPs) together with protein tyrosine kinases (PTKs) regulate protein tyrosine phosphorylation. Their abnormal functions are involved in the initiation and maintenance of the oncogenic state in human. 1 Several synthetic tetronic acid derivatives related to the natural product RK-682 (R)-1 ( Figure 1 ) have been evaluated as inhibitors of dual-specificity phosphatases VHR and CDC-25B and four derivatives were shown to be the most potent inhibitors of CDC-25B described so far. 
RESULTS AND DISCUSSION
Ethyl 4-chloroacetoacetate was converted to intermediate 5 after 7 steps. Synthesis of sixmembered ring homologues 6 and 7 was carried out via coupling between 5 and palmitic acid mediated by N,N'-dicyclohexylcarbodiimide (DCC) (Scheme 1). The screening of their PTP inhibitory activity and comparison with racemic RK-682 (rac-1) has shown that the six-membered compounds 6 and 7 were inactive in the LMW-PTP inhibition assays, displayed reduced PTP-1B inhibitory activity but kept similar activity against CDC-25B. In contrast, dioxinanes 8 and 9 showed potent inhibitory activity for the three phosphatases analyzed (Table 1) . 
CONCLUSION
Compounds 6 and 7 displayed greater selectivity to PTP-1B and CDC-25B than racemic RK-682. Dioxinones 8 and 9 have shown similar PTPase inhibitory activity as the natural compound RK-682.
